Clinical Trial Update: A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis

View source ↗

Summary

A retrospective study evaluating the efficacy and safety of Lolatinib in ALK-positive non-small cell lung cancer patients with brain metastases and/or meningeal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alk-positive Non-small Cell Lung Cancer
• Brain Metastases
• Meningeal Metastasis

Drugs mentioned

• Lolatinib

Snippet

Sponsor: Sichuan Cancer Hospital and Research Institute | Conditions: ALK-positive Non-small Cell Lung Cancer, Brain Metastases | Status: ACTIVE_NOT_RECRUITING